CXM

5.26%

4.0¢ centrex limited

Ann: Trading Halt, page-54

First 54 Last

Share
Profile

Follow
fup

1,126 Posts.

102

01/02/24

23:22

Post #: 72194998
Share

Originally posted by tmath: ↑

Time will tell.

Expand

indeed

Originally posted by Happ: ↑

There is no need for you to misinform here. Maybe start reading the announcements and analyse them.

MD's presentation 29 November 2023:

Page 12 - Original capital spend 25.7mln, Revised capital spend 17.6mln due in part to 4mln raised in August 2023.
So the reduction was 15% and not 30%. If they went on your advice and engaged Big4 consultants their costs would have probably tripled. Regarding cost overruns, yes they may happen but based on what I have seen with this company it is unlikely. There is enough phosphate mining and civil engineering skills.

Page 16 - Breakdown of upfront capital cost - about 9mln in the first half and 8mln in the second half.

Page 17 - Working capital 6mln.

Recent announcement - Raising 10mln (7 mln for capital costs and 3mln for working capital)

Sales of product in the first half should bring free cash of at least 10mln (50,000 tonnes x 2 quarters x 100 profit margin). The working capital facility from Export Finance was undrawn by about 3mln from memory.

So the capital costs in the second half are covered based on projections.

If anything bank debt would be available in the next few quarters for sure to be secured against cashflows, if they ever need debt at all.

They opportunity to buy up at current prices will be drying up as quickly as phosphate rock once people begin realising that the company is profitable and fully funded for expansion. I expect it will re-rate to market value rather quickly.

Expand

yes I too am looking forward to a re rate, especially if this is opening at the cap raise price tmr

CXM Price at posting: 6.9¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 11 more messages in this thread...

First 54 Last

Add CXM (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.002(5.26%)		Mkt cap ! $34.65M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$5.255K	134.7K

Buyers (Bids)

No.	Vol.	Price($)
1	120000	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	378517	2

View Market Depth

No.	Vol.	Price($)
1	120000	0.039
2	169499	0.038
1	26500	0.037
3	447234	0.036
4	237786	0.035

Price($)	Vol.	No.
0.040	378517	2
0.042	122633	3
0.043	460739	3
0.044	343896	3
0.045	22244	1

Last trade - 12.13pm 02/10/2024 (20 minute delay)

CXM (ASX) Chart

Ann: Trading Halt, page-54

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-54

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News